At a glance
- Originator Tobishi
- Class Antineoplastics; Cyclic peptides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 16 Jan 2001 No-Development-Reported for Cancer metastases in Japan (Unknown route)
- 16 Jan 2001 No-Development-Reported for Colorectal cancer in Japan (Unknown route)